Drug intelligence / Profile preview

StealthX Therapeutic Exosomes

Development stage
Preclinical
Lead developer
Capricor Therapeutics
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intramuscular, Intravenous, Oral, Inhalation, Intranasal, In Situ
01

Overview

StealthX Therapeutic Exosomes is a proprietary exosome-based platform developed by Capricor Therapeutics for the targeted delivery of various therapeutic payloads, including oligonucleotides, proteins, and small molecules. The platform leverages nano-sized extracellular vesicles (exosomes) engineered for specific surface protein expression and cargo loading. These exosomes are designed to mediate paracrine effects such as anti-inflammatory, anti-fibrotic, and immunomodulatory actions. While the platform is being evaluated for a wide range of diseases, preclinical research has specifically explored its use in treating Duchenne muscular dystrophy (DMD) through the delivery of phosphorodiamidate morpholino oligomers (PMOs).

Brand names
StealthX
Other names
StealthX platformCapricor therapeutic exosomes

Beyond the preview

Go deeper on StealthX Therapeutic Exosomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on StealthX Therapeutic Exosomes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call